The Journal of Korean Diabetes

Search

Page Path

HOME
Search

Opinion

당뇨병 약제, 뇌 건강에 대한 새로운 기대: 가능성과 불확실성: 김수경; J Korean Diabetes. 2026;27(2):51-55. Published online June 30, 2026; DOI: https://doi.org/10.4093/jkd.2026.27.2.51

Statement

당뇨병신장질환에서 GLP-1수용체작용제의 역할: 최근 연구 결과: 김진화; J Korean Diabetes. 2025;26(1):5-9. Published online March 30, 2025; DOI: https://doi.org/10.4093/jkd.2025.26.1.5

Focused Issues

비만당뇨병의 관리 전략: 김미숙, 이승환; J Korean Diabetes. 2024;25(3):165-171. Published online September 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.3.165

GLP-1수용체작용제: 정승민; J Korean Diabetes. 2024;25(2):69-75. Published online June 30, 2024; DOI: https://doi.org/10.4093/jkd.2024.25.2.69

Information Desks

최신 당뇨병 치료제의 특징: 윤누리; J Korean Diabetes. 2023;24(3):148-153. Published online September 30, 2023; DOI: https://doi.org/10.4093/jkd.2023.24.3.148

Focused Issues

당뇨병 주사제: Glucagon-Like Peptide-1 수용체작용제: Inkuk Lee, Eun Seok Kang; J Korean Diabetes. 2019;20(3):149-156. Published online October 2, 2019; DOI: https://doi.org/10.4093/jkd.2019.20.3.149
Cited By 2

Opinion

식사 중 탄수화물은 언제 먹어야 하나: Jae Hyun Bae, Young Min Cho; J Korean Diabetes. 2018;19(4):193-199. Published online January 8, 2019; DOI: https://doi.org/10.4093/jkd.2018.19.4.193
Cited By 1

2018년 미국당뇨병학회 진료지침 속의 작지만 큰 변화: Jeong Hyun Park; J Korean Diabetes. 2018;19(2):71-75. Published online July 9, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.2.71
Cited By 1

Focused Issues

제2형 당뇨병 약제치료 지침 2017 개정안: Glucagon-Like Peptide-1 수용체작용제: Hyun Jin Kim; J Korean Diabetes. 2018;19(1):35-40. Published online April 13, 2018; DOI: https://doi.org/10.4093/jkd.2018.19.1.35
Cited By 1

Volume 27, No. 2

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

4,291	Nutritional Strategies for Prevention of Postprandial Glucose Spikes
6,342	GLP-1/GIP Receptor Agonists: Mechanism of Action of Tirzepatide
9,127	Guidelines for the Use of 2023 Food Exchange Lists for Diabetes Meal Planning
4,754	GLP-1 Receptor Agonist
1,595	Clinical Significance of Time-Based Glycemic Metrics in Continuous Glucose Monitoring

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2026 by Korean Diabetes Association. All rights reserved.